I left MSKCC in 1996 and moved with my family to Alabama to work at the University of Alabama at Birmingham in Surgical Oncology. The KACF fellowship helped me become a local expert in the management of soft tissue tumors of all sites. Our group at UAB has published articles on the role of preoperative…

I am currently the CEO of ZIOPHARM Oncology, a cancer drug development biotech company based out of New York and Boston. One of the lead drugs we are developing (Zymafos / Palifosfamide) is being developed in soft tissue sarcoma. This is a small molecule that works in a similar way to ifosfamide, with hopefully better…